SUN PHARMACEUTICAL INDUSTRIES INC recalls Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only, Distributed by: Sun Pharmaceutical
Recalled November 9, 2022 · FDA recall D-0024-2023 · SUN PHARMACEUTICAL INDUSTRIES
Hazard
Presence of Foreign Substance · FDA Class II
Units
N/A
Sold at
Nationwide with the United States
Description
Presence of Foreign Substance
Product
Buprenorphine and Naloxone Sublingual Tablets 8 mg/2 mg, 30-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512 Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India; NDC 62756-970-83
Manufacturer(s)
SUN PHARMACEUTICAL INDUSTRIES INC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →